Que Oncology
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor (NCT03518138) | Que Oncology | 2018-10-24 |
| Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen (NCT04080297) | Que Oncology | 2014-01-10 |
Track Que Oncology automatically
Every clearance here is in the API, with alerts when new ones post.